Article Information
History
- February 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tanuja Chitnis, MD1,
- John Foley, MD2,
- Carolina Ionete, MD3,
- Nabil K. El Ayoubi, MD4,
- Shrishti Saxena, MS1,
- Patricia Gaitan-Walsh, MPH1,
- Hrishikesh Lokhande, MS1,
- Anu Paul, PhD1,
- Fermisk Saleh, BS1,
- Howard Weiner, MD1,
- Jennifer L. Venzie, PhD5,
- Ferhan Qureshi, BS6,†,
- Michael J. Becich, MS6,*,
- Fatima Rubio da Costa, PhD6,*,
- Victor M. Gehman, PhD6,*,
- Fujun Zhang, MS6,*,
- Anisha Keshavan, PhD6,
- Kian Jalaleddini, PhD6,
- Ati Ghoreyshi, PhD6 and
- Samia J. Khoury, MD4
- 1Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 2Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA
- 3University of Massachusetts Medical School, Worcester, MA, USA
- 4American University of Beirut, Beirut, Lebanon
- 5The Lockwood Group, Stamford, CT, USA
- 6Octave Bioscience, Inc., Menlo Park, CA, USA
- ↵†Correspondence: Ferhan Qureshi, 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025, USA, fqureshi{at}octavebio.com, Phone: 650-224-3072, Fax: 650-479-8876
Posted February 10, 2023.
Clinical Validation of a Multi-protein, Serum-based Assay for Disease Activity Assessments in Multiple Sclerosis
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos